Curcumin Nanotechnologies and Its Anticancer Activity

Nutrition and Cancer

Volumn 69, Issue 3, 2017, Pages 381-393

  Subramani, Parasuraman Aiya ^a,b   Panati, Kalpana ^c   Narala, Venkata Ramireddy ^a  

^a YOGI VEMANA UNIVERSITY   (India)

^b VELS INSTITUTE OF SCIENCE   (India)

^c Government College for Men (A)   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COPOLYMER; CURCUMIN; CYCLODEXTRIN; LIPOSOME; METAL COMPLEX; NIOSOME; POLYMETHACRYLIC ACID; SOLID LIPID NANOPARTICLE; ANTINEOPLASTIC AGENT; MAGNETITE NANOPARTICLE; POLYMER;

AEROSOL; ANTINEOPLASTIC ACTIVITY; COLLOID; DRUG BIOAVAILABILITY; DRUG RESEARCH; DRUG SYNTHESIS; DRUG USE; HUMAN; NANOTECHNOLOGY; POLYMERIZATION; REVIEW; ANIMAL; BIOAVAILABILITY; CHEMISTRY; CLINICAL TRIAL (TOPIC); DISEASE MODEL; PARTICLE SIZE; PHARMACOKINETICS; TUMOR CELL LINE;

AEROSOLS; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CELL LINE, TUMOR; CLINICAL TRIALS AS TOPIC; CURCUMIN; CYCLODEXTRINS; DISEASE MODELS, ANIMAL; HUMANS; LIPOSOMES; MAGNETITE NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; POLYMERS;

EID: 85014908324     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2017.1285405     Document Type: Review

References (132)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al.:Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108, 2015.
2. Islami F, Torre LA, Jemal A, :Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res 4, 327–338, 2015.
3. Nair KS, Raj S, Tiwari VK, Piang LK, :Cost of treatment for cancer:experiences of patients in public hospitals in India. Asian Pac J Cancer Prev 14, 5049–5054, 2013.
4. Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, et al.:American society of clinical oncology statement:a conceptual framework to assess the value of cancer treatment options. J Clin Oncol 33, 2563–2577, 2015.
5. Gillet JP, Gottesman MM, :Mechanisms of multidrug resistance in cancer. Methods Mol Biol 596, 47–76, 2010.
6. Cojoc M, Mabert K, Muders MH, Dubrovska A, :A role for cancer stem cells in therapy resistance:cellular and molecular mechanisms. Semin Cancer Biol 31, 16–27, 2015.
7. Rosa GM, Gigli L, Tagliasacchi MI, Di Iorio C, Carbone F, et al.:Update on cardiotoxicity of anti-cancer treatments. Eur J Clin Invest 46, 264–284, 2016.
8. Vassilakopoulou M, Boostandoost E, Papaxoinis G, de La Motte Rouge T, Khayat D, et al.:Anticancer treatment and fertility:Effect of therapeutic modalities on reproductive system and functions. Crit Rev Oncol Hematol 97, 328–334, 2016.
9. Mirabile A, Numico G, Russi EG, Bossi P, Crippa F, et al.:Sepsis in head and neck cancer patients treated with chemotherapy and radiation:Literature review and consensus. Crit Rev Oncol Hematol 95, 191–213, 2015.
10. Liu L, Ye Q, Lu M, Lo YC, Hsu YH, et al.:A new approach to reduce toxicities and to improve bioavailabilities of platinum-containing anti-cancer nanodrugs. Sci Rep 5, 10881, 2015.
11. Cai L, Xu G, Shi C, Guo D, Wang X, et al.:Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin:a synergistic combination nanotherapy for ovarian cancer treatment. Biomaterials 37, 456–468, 2015.
12. England CG, Miller MC, Kuttan A, Trent JO, Frieboes HB, :Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles. Eur J Pharm Biopharm 92, 120–129, 2015.
13. Gupta SC, Sung B, Kim JH, Prasad S, Li S, et al.:Multitargeting by turmeric, the golden spice:from kitchen to clinic. Mol Nutr Food Res 57, 1510–1528, 2013.
14. Mileo AM, Miccadei S, :Polyphenols as modulator of oxidative stress in cancer disease:new therapeutic strategies. Oxid Med Cell Longev 2016, 6475624, 2016.
15. Fantini M, Benvenuto M, Masuelli L, Frajese GV, Tresoldi I, et al.:In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs:perspectives on cancer treatment. Int J Mol Sci 16, 9236–9282, 2015.
16. Fridlender M, Kapulnik Y, Koltai H, :Plant derived substances with anti-cancer activity:from folklore to practice. Front Plant Sci 6, 799, 2015.
17. Pan MH, Huang TM, Lin JK, :Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27, 486–494, 1999.
18. Ravindranath V, Chandrasekhara N, :Metabolism of curcumin–studies with [3H]curcumin. Toxicology 22, 337–344, 1981.
19. Torchilin VP, :Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov 13, 813–827, 2014.
20. Prasad S, Tyagi AK, Aggarwal BB, :Recent developments in delivery, bioavailability, absorption and metabolism of curcumin:the golden pigment from golden spice. Cancer Res Treat 46, 2–18, 2014.
21. Patra S, Roy E, Karfa P, Kumar S, Madhuri R, et al.:Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment. ACS Appl Mater Interfaces 7, 9235–9246, 2015.
22. Hu L, Kong D, Hu Q, Gao N, Pang S, :Evaluation of high-performance curcumin nanocrystals for pulmonary drug delivery both in vitro and in vivo. Nanoscale Res Lett 10, 381, 2015.
23. Subramani PA, Narala VR, :Challenges of curcumin bioavailability:novel aerosol remedies. Nat Prod Commun 8, 121–124, 2013.
24. Schraufstatter E, Bernt H, :Antibacterial action of curcumin and related compounds. Nature 164, 456, 1949.
25. Priyadarsini K, :The chemistry of curcumin:from extraction to therapeutic agent. Molecules 19, 20091, 2014.
26. Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F, :Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomed Nanotechnol Biol Med 2, 8–21, 2006.
27. Taki M, Tagami T, Fukushige K, Ozeki T, :Fabrication of nanocomposite particles using a two-solution mixing-type spray nozzle for use in an inhaled curcumin formulation. Int J Pharm 511, 104–110, 2016.
28. Pandita D, Kumar S, Lather V, :Hybrid poly(lactic-co-glycolic acid) nanoparticles:design and delivery prospectives. Drug Discov Today 20, 95–104, 2015.
29. Yallapu MM, Gupta BK, Jaggi M, Chauhan SC, :Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci 351, 19–29, 2010.
30. Yallapu MM, Khan S, Maher DM, Ebeling MC, Sundram V, et al.:Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials 35, 8635–8648, 2014.
31. Waghela BN, Sharma A, Dhumale S, Pandey SM, Pathak C, :Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells. PLoS ONE 10, e0117526, 2015.
32. Masloub SM, Elmalahy MH, Sabry D, Mohamed WS, Ahmed SH, :Comparative evaluation of PLGA nanoparticle delivery system for 5-fluorouracil and curcumin on squamous cell carcinoma. Arch Oral Biol 64, 1–10, 2015.
33. Das RK, Kasoju N, Bora U, :Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomed Nanotechnol Biol Med 6, 153–160, 2010.
34. Sanoj Rejinold N, Muthunarayanan M, Divyarani VV, Sreerekha PR, Chennazhi KP, et al.:Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. J Colloid Interface Sci 360, 39–51, 2011.
35. Zhou N, Zan X, Wang Z, Wu H, Yin D, et al.:Galactosylated chitosan–polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin. Carbohydr Polym 94, 420–429, 2013.
36. Anitha A, Deepa N, Chennazhi KP, Lakshmanan V-K, Jayakumar R, :Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment. Biochim Biophys Acta (BBA)–Gen Subj 1840, 2730–2743, 2014.
37. Chuah LH, Roberts CJ, Billa N, Abdullah S, Rosli R, :Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles. Colloids Surf B 116, 228–236, 2014.
38. Delmar K, Bianco-Peled H, :Composite chitosan hydrogels for extended release of hydrophobic drugs. Carbohydr Polym 136, 570–580, 2016.
39. Loch-Neckel G, Santos-Bubniak L, Mazzarino L, Jacques AV, Moccelin B, et al.:Orally administered chitosan-coated polycaprolactone nanoparticles containing curcumin attenuate metastatic melanoma in the lungs. J Pharm Sci 104, 3524–3534, 2015.
40. Palange AL, Di Mascolo D, Carallo C, Gnasso A, Decuzzi P, :Lipid–polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells. Nanomed Nanotechnol Biol Med 10, 991–1002, 2014.
41. Kumar SSD, Mahesh A, Mahadevan S, Mandal AB, :Synthesis and characterization of curcumin loaded polymer/lipid based nanoparticles and evaluation of their antitumor effects on MCF-7 cells. Biochim Biophys Acta (BBA)–Gen Subj 1840, 1913–1922, 2014.
42. Pillai JJ, Thulasidasan AK, Anto RJ, Chithralekha DN, Narayanan A, et al.:Folic acid conjugated cross-linked acrylic polymer (FA-CLAP) hydrogel for site specific delivery of hydrophobic drugs to cancer cells. J Nanobiotechnol 12, 25, 2014.
43. Teong B, Lin CY, Chang SJ, Niu GC, Yao CH, et al.:Enhanced anti-cancer activity by curcumin-loaded hydrogel nanoparticle derived aggregates on A549 lung adenocarcinoma cells. J Mater Sci Mater Med 26, 5357, 2015.
44. Ryan RO, :Nanobiotechnology applications of reconstituted high density lipoprotein. J Nanobiotechnol 8, 28, 2010.
45. Oda MN, Hargreaves PL, Beckstead JA, Redmond KA, Van Antwerpen R, et al.:Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B. J Lipid Res 47, 260–267, 2006.
46. Redmond KA, Nguyen TS, Ryan RO, :All-trans-retinoic acid nanodisks. Int J Pharm 339, 246–250, 2007.
47. Ghosh M, Singh AT, Xu W, Sulchek T, Gordon LI, et al.:Curcumin nanodisks:formulation and characterization. Nanomedicine 7, 162–167, 2011.
48. Bertoni F, Ponzoni M, :The cellular origin of mantle cell lymphoma. Int J Biochem Cell Biol 39, 1747–1753, 2007.
49. Singh AT, Ghosh M, Forte TM, Ryan RO, Gordon LI, :Curcumin nanodisk-induced apoptosis in mantle cell lymphoma. Leuk Lymphoma 52, 1537–1543, 2011.
50. Lima FR, Kahn SA, Soletti RC, Biasoli D, Alves T, et al.:Glioblastoma:therapeutic challenges, what lies ahead. Biochim Biophys Acta 1826, 338–349, 2012.
51. Ghosh M, Ryan RO, :ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells. Nanomedicine (Lond) 9, 763–771, 2014.
52. Crosby NM, Ghosh M, Su B, Beckstead JA, Kamei A, et al.:Anti-CD20 single chain variable antibody fragment-apolipoprotein A-I chimera containing nanodisks promote targeted bioactive agent delivery to CD20-positive lymphomas. Biochem Cell Biol 93, 343–350, 2015.
53. Kunwar A, Barik A, Pandey R, Priyadarsini KI, :Transport of liposomal and albumin loaded curcumin to living cells:An absorption and fluorescence spectroscopic study. Biochim Biophys Acta (BBA)–Gen Subj 1760, 1513–1520, 2006.
54. Takahashi M, Uechi S, Takara K, Asikin Y, Wada K, :Evaluation of an oral carrier system in rats:bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem 57, 9141–9146, 2009.
55. Jin HH, Lu Q, Jiang JG, :Curcumin liposomes prepared with milk fat globule membrane phospholipids and soybean lecithin. J Dairy Sci 99, 1780–1790, 2016.
56. Lin Y-L, Liu Y-K, Tsai N-M, Hsieh J-H, Chen C-H, et al.:A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells. Nanomed Nanotechnol Biol Med 8, 318–327, 2012.
57. Orr WS, Denbo JW, Saab KR, Myers AL, Ng CY, et al.:Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition. Surgery 151, 736–744, 2012.
58. Li L, Braiteh FS, Kurzrock R, :Liposome-encapsulated curcumin:in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104, 1322–1331, 2005.
59. Wang D, Veena MS, Stevenson K, Tang C, Ho B, et al.:Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clin Cancer Res 14, 6228–6236, 2008.
60. Chen C, Johnston TD, Jeon H, Gedaly R, McHugh PP, et al.:An in vitro study of liposomal curcumin:Stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int J Pharm 366, 133–139, 2009.
61. Moku G, Gulla SK, Nimmu NV, Khalid S, Chaudhuri A, :Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes. Biomater Sci 4, 627–638, 2016.
62. Barui S, Saha S, Yakati V, Chaudhuri A, :Systemic codelivery of a homoserine derived ceramide analogue and curcumin to tumor vasculature inhibits mouse tumor growth. Mol Pharm 13, 404–419, 2016.
63. McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, et al.:Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 59, 4291–4296, 1999.
64. Narayanan NK, Nargi D, Randolph C, Narayanan BA, :Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 125, 1–8, 2009.
65. Uchegbu IF, Vyas SP, :Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172, 33–70, 1998.
66. Kumar GP, Rajeshwarrao P, :Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B 1, 208–219, 2011.
67. Mandal S, Banerjee C, Ghosh S, Kuchlyan J, Sarkar N, :Modulation of the photophysical properties of curcumin in nonionic surfactant (Tween-20) forming micelles and niosomes:a comparative study of different microenvironments. J Phys Chem B 117, 6957–6968, 2013.
68. Rungphanichkul N, Nimmannit U, Muangsiri W, Rojsitthisak P, :Preparation of curcuminoid niosomes for enhancement of skin permeation. Int J Pharm Sci 66, 570–575, 2011.
69. Tavano L, Muzzalupo R, Picci N, de Cindio B, :Co-encapsulation of antioxidants into niosomal carriers:gastrointestinal release studies for nutraceutical applications. Colloids Surf B 114, 82–88, 2014.
70. Wang P, Zhang L, Peng H, Li Y, Xiong J, et al.:The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Mater Sci Eng C 33, 4802–4808, 2013.
71. Wang J, Zhu R, Sun D, Sun X, Geng Z, et al.:Intracellular uptake of curcumin-loaded solid lipid nanoparticles exhibit anti-inflammatory activities superior to those of curcumin through the NF-kappaB signaling pathway. J Biomed Nanotechnol 11, 403–415, 2015.
72. Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, et al.:Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull 34, 660–665, 2011.
73. Milano F, Mari L, van de Luijtgaarden W, Parikh K, Calpe S, et al.:Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response. Front Oncol 3, 137, 2013.
74. Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, et al.:Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother Pharmacol 69, 65–70, 2012.
75. Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, et al.:A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother Pharmacol 71, 1521–1530, 2013.
76. Morimoto T, Sunagawa Y, Katanasaka Y, Hirano S, Namiki M, et al.:Drinkable preparation of Theracurmin exhibits high absorption efficiency—a single-dose, double-blind, 4-way crossover study. Biol Pharm Bull 36, 1708–1714, 2013.
77. Kang M, Ho JN, Kook HR, Lee S, Oh JJ, et al.:Theracurmin(R) efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest. Oncol Rep 35, 1463–1472, 2015.
78. Thakral S, Thakral NK, Majumdar DK, :Eudragit:a technology evaluation. Expert Opin Drug Deliv 10, 131–149, 2013.
79. Dandekar P, Dhumal R, Jain R, Tiwari D, Vanage G, et al.:Toxicological evaluation of pH-sensitive nanoparticles of curcumin:acute, sub-acute and genotoxicity studies. Food Chem Toxicol 48, 2073–2089, 2010.
80. Prajakta D, Ratnesh J, Chandan K, Suresh S, Grace S, et al.:Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer. J Biomed Nanotechnol 5, 445–455, 2009.
81. Kumar S, Kesharwani SS, Mathur H, Tyagi M, Bhat GJ, et al.:Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin. Eur J Pharm Sci 82, 86–96, 2016.
82. Li J, Lee IW, Shin GH, Chen X, Park HJ, :Curcumin-Eudragit(R) E PO solid dispersion:a simple and potent method to solve the problems of curcumin. Eur J Pharm Biopharm 94, 322–332, 2015.
83. Madhavi M, Madhavi K, Jithan AV, :Preparation and in vitro/in vivo characterization of curcumin microspheres intended to treat colon cancer. J Pharm Bioallied Sci 4, 164–171, 2012.
84. Szejtli J, :Cyclodextrin Technology. Springer, 1988.
85. Vassiliou A, :Authorising the Placing on the Market of Alpha-Cyclodextrin as a Novel Food Ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council. Brussels:Official Journal of the European Union, 2008.
86. Yallapu MM, Jaggi M, Chauhan SC, :β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B 79, 113–125, 2010.
87. Yallapu MM, Dobberpuhl MR, Maher DM, Jaggi M, Chauhan SC, :Design of curcumin loaded cellulose nanoparticles for prostate cancer. Curr Drug Metab 13, 120–128, 2012.
88. Tan Q, Li Y, Wu J, Mei H, Zhao C, et al.:An optimized molecular inclusion complex of diferuloylmethane:enhanced physical properties and biological activity. Int J Nanomed 5, 5385–5393, 2012.
89. Yadav VR, Prasad S, Kannappan R, Ravindran J, Chaturvedi MM, et al.:Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem Pharmacol 80, 1021–1032, 2010.
90. Yadav VR, Suresh S, Devi K, Yadav S, :Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS PharmSciTech 10, 752–762, 2009.
91. Kazemi-Lomedasht F, Rami A, Zarghami N, :Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer. Adv Pharm Bull 3, 127–130, 2013.
92. Rocks N, Bekaert S, Coia I, Paulissen G, Gueders M, et al.:Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. Br J Cancer 107, 1083–1092, 2012.
93. Rachmawati H, Edityaningrum CA, Mauludin R, :Molecular inclusion complex of curcumin-beta-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel. AAPS PharmSciTech 14, 1303–1312, 2013.
94. Ndong Ntoutoume GM, Granet R, Mbakidi JP, Bregier F, Leger DY, et al.:Development of curcumin-cyclodextrin/cellulose nanocrystals complexes:new anticancer drug delivery systems. Bioorg Med Chem Lett 26, 941–945, 2016.
95. Swaminathan S, Cavalli R, Trotta F, :Cyclodextrin-based nanosponges:a versatile platform for cancer nanotherapeutics development. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8, 579–601, 2016.
96. Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC, :Advanced drug delivery systems of curcumin for cancer chemoprevention. Cancer Prev Res (Phila) 4, 1158–1171, 2011.
97. Kasinathan N, Amirthalingam M, Reddy ND, Jagani HV, Volety SM, et al.:In-situ implant containing PCL-curcumin nanoparticles developed using design of experiments. Drug Deliv 1–9, 2014.
98. Sridhar R, Ravanan S, Venugopal JR, Sundarrajan S, Pliszka D, et al.:Curcumin- and natural extract-loaded nanofibres for potential treatment of lung and breast cancer:in vitro efficacy evaluation. J Biomater Sci Polym Ed 25, 985–998, 2014.
99. Bansal SS, Kausar H, Vadhanam MV, Ravoori S, Pan J, et al.:Curcumin implants, not curcumin diet, inhibit estrogen-induced mammary carcinogenesis in ACI rats. Cancer Prev Res (Phila) 7, 456–465, 2014.
100. Aqil F, Jeyabalan J, Kausar H, Bansal SS, Sharma RJ, et al.:Multi-layer polymeric implants for sustained release of chemopreventives. Cancer Lett 326, 33–40, 2012.
101. Varaprasad K, Mohan YM, Vimala K, Mohana Raju K, :Synthesis and characterization of hydrogel-silver nanoparticle-curcumin composites for wound dressing and antibacterial application. J Appl Polym Sci 121, 784–796, 2011.
102. Manju S, Sreenivasan K, :Gold nanoparticles generated and stabilized by water soluble curcumin–polymer conjugate:blood compatibility evaluation and targeted drug delivery onto cancer cells. J Colloid Interface Sci 368, 144–151, 2012.
103. Siddiqui MA, Ahamed M, Ahmad J, Majeed Khan MA, Musarrat J, et al.:Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin. Food Chem Toxicol 50, 641–647, 2012.
104. Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, et al.:Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials 32, 1890–1905, 2011.
105. Ito A, Shinkai M, Honda H, Kobayashi T, :Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 100, 1–11, 2005.
106. Lu AH, Salabas EL, Schuth F, :Magnetic nanoparticles:synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl 46, 1222–1244, 2007.
107. Yallapu MM, Othman SF, Curtis ET, Bauer NA, Chauhan N, et al.:Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomed 7, 1761–1779, 2012.
108. Yallapu MM, Ebeling MC, Khan S, Sundram V, Chauhan N, et al.:Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther 12, 1471–1480, 2013.
109. Balasubramanian S, Girija AR, Nagaoka Y, Iwai S, Suzuki M, et al.:Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation:a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia. Int J Nanomed 9, 437–459, 2014.
110. Fang JH, Chiu TL, Huang WC, Lai YH, Hu SH, et al.:Dual-targeting lactoferrin-conjugated polymerized magnetic polydiacetylene-assembled nanocarriers with self-responsive fluorescence/magnetic resonance imaging for in vivo brain tumor therapy. Adv Healthc Mater 5, 688–695, 2016.
111. Selvam P, El-Sherbiny IM, Smyth HD, :Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers. J Aerosol Med Pulm Drug Deliv 24, 25–34, 2011.
112. El-Sherbiny IM, Smyth HD, :Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles. Mol Pharm 9, 269–280, 2012.
113. McClure R, Yanagisawa D, Stec D, Abdollahian D, Koktysh D, et al.:Inhalable curcumin:offering the potential for translation to imaging and treatment of Alzheimer's disease. J Alzheimers Dis 44, 283–295, 2015.
114. Lin Y-L, Liu Y-K, Tsai N-M, Hsieh J-H, Chen C-H, et al.:A Lipo-PEG–PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells. Nanomed Nanotechnol Biol Med 8, 318–327.
115. Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, et al.:Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomed Nanotechnol Biol Med 8, 440–451, 2012.
116. Wang D, Veena MS, Stevenson K, Tang C, Ho B, et al.:liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor κB by an AKT-independent pathway. Am Assoc Cancer Res 14, 6228–6236, 2008.
117. Li C, Zhang Y, Su T, Feng L, Long Y, et al.:Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin. Int J Nanomed 7, 5995–6002, 2012.
118. Liu L, Sun L, Wu Q, Guo W, Li L, et al.:Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. Int J Pharm 443, 175–182, 2013.
119. Gou M, Men K, Shi H, Xiang M, Zhang J, et al.:Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 3, 1558–1567, 2011.
120. Gong C, Deng S, Wu Q, Xiang M, Wei X, et al.:Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 34, 1413–1432, 2013.
121. Lee WH, Loo CY, Ong HX, Traini D, Young PM, et al.:Synthesis and characterization of inhalable flavonoid nanoparticle for lung cancer cell targeting. J Biomed Nanotechnol 12, 371–386, 2016.
122. Zhang L, Zhu W, Yang C, Guo H, Yu A, et al.:A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting. Int J Nanomed 7, 151–162, 2012.
123. Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, et al.:Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 58, 2095–2099, 2010.
124. Duan J, Zhang Y, Han S, Chen Y, Li B, et al.:Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 400, 211–220, 2010.
125. Chiu SS, Lui E, Majeed M, Vishwanatha JK, Ranjan AP, et al.:Differential distribution of intravenous curcumin formulations in the rat brain. Anticancer Res 31, 907–911, 2011.
126. Bisht S, Mizuma M, Feldmann G, Ottenhof NA, Hong SM, et al.:Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther 9, 2255–2264, 2010.
127. Babaei E, Sadeghizadeh M, Hassan ZM, Feizi MAH, Najafi F, et al.:Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo. Int Immunopharmacol 12, 226–234, 2012.
128. Zaman MS, Chauhan N, Yallapu MM, Gara RK, Maher DM, et al.:Curcumin nanoformulation for cervical cancer treatment. Sci Rep 6, 20051, 2016.
129. Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, et al.:Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 79, 330–338, 2010.
130. Hu B, Sun D, Sun C, Sun Y-F, Sun H-X, et al.:A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. Biochem Biophys Res Commun 468, 525–532, 2015.
131. Wanninger S, Lorenz V, Subhan A, Edelmann FT, :Metal complexes of curcumin–synthetic strategies, structures and medicinal applications. Chem Soc Rev 44, 4986–5002, 2015.
132. Tang H, Murphy CJ, Zhang B, Shen Y, Van Kirk EA, et al.:Curcumin polymers as anticancer conjugates. Biomaterials 31, 7139–7149, 2010.